Fierce Pharma
DECEMBER 21, 2023
Big Pharma companies have often talked about the major opportunities that await in China. | Big Pharma companies have often talked about the major opportunities that await in China. But as price cuts play out and internal priorities shift, multinational companies are reworking their business models in the country.
MedCity News
DECEMBER 21, 2023
Guidehealth, a nascent value-based care enablement startup, acquired Arcadia’s value-based care service division. Acquiring this business unit allows Guidehealth to provide health systems with a platform that helps them succeed in value-based care arrangements while still maintaining their patient volume levels.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
DECEMBER 21, 2023
As Vertex Pharmaceuticals and CRISPR Therapeutics lay the groundwork for the launch of their CRISPR-based gene-editing therapy Casgevy, one doctor who treats sickle cell disease patients is already | As Vertex Pharmaceuticals and CRISPR Therapeutics lay the groundwork for the launch of their world-first CRISPR-based gene therapy Casgevy, one doctor who treats sickle cell disease patients is already seeing strong demand.
European Pharmaceutical Review
DECEMBER 21, 2023
A study carried out by scientists from the University of Texas at Arlington (UTA) has found that using carbonated water in chromatography makes this relatively common chemical technique more environmentally benign. The research, led by Daniel W. Armstrong, the Welch Distinguished Professor of Chemistry and Biochemistry at UTA, was published in Green Chemistry.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
DECEMBER 21, 2023
Two years ago, with a favorable ruling and a slap-on-the | A favorable ruling two years ago had Servier hoping that its decades-long litigation surrounding weight-loss pill Mediator was finally over. But an appeal from prosecutors now leaves the company facing a hefty penalty.
MedCity News
DECEMBER 21, 2023
Of those with employer-sponsored insurance, 31% of lower-income adults reported having trouble paying their medical bills, versus 13% of higher-income adults, according to a new report from KFF.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
DECEMBER 21, 2023
Right-now value could come from extractive AI, a tool that gives organizations the power to put even handwritten text sent via images or PDF by digital fax into a structured data play.
Fierce Pharma
DECEMBER 21, 2023
Ionis Pharmaceuticals and AstraZeneca are wrapping up the year with a much-anticipated present from the FDA: an approval for the companies’ transthyretin amyloidosis (ATTR) drug Wainua. | The approval in hereditary transthyretin-mediated amyloid polyneuropathy, which affects around 40,000 to 50,000 patients globally, sets the stage for a potential label expansion down the line to treat the broader transthyretin amyloid cardiomyopathy patient population.
European Pharmaceutical Review
DECEMBER 21, 2023
Piramal Pharma Solutions has officially opened new facilities at its antibody-drug conjugate (ADC) manufacturing facility in Grangemouth, Scotland. This expansion enhances the site’s capacity by 70-80 percent and will enable scale-up of commercial ADC manufacturing batches. “The global ADC market is growing strongly and so is the pipeline at Grangemouth, necessitating additional capacity to meet customer demand,” said Peter DeYoung, Chief Executive Officer, Piramal Pharma Solutions.
Fierce Pharma
DECEMBER 21, 2023
Following the U.S. | Following the U.S. Federal Trade Commission's recent crackdown on "improper" patents in the FDA's Orange Book, GSK, Amneal and Kaleo have made the requested changes.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
MedCity News
DECEMBER 21, 2023
Knownwell’s $20 million Series A funding round was led by A16Z and included participation from Flare Capital Partners. The company also launched an adolescent metabolic health program.
pharmaphorum
DECEMBER 21, 2023
An organisation representing the interests of patients with prostate cancer has published a manifesto ahead of the EU elections next year, calling for more screening for the disease in EU member states.
MedCity News
DECEMBER 21, 2023
Javier Gonzalez, Chief Growth and Commercial Officer at Abarca, about why payers are increasingly looking for alternatives to the traditional PBM model.
Pharmaceutical Technology
DECEMBER 21, 2023
Genevoyager has announced the opening of contract development and manufacturing organisation facility to manufacture gene therapy products.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
DECEMBER 21, 2023
Sanofi ends development of CEACAM5-targeting ADC tusamitamab ravtansine after it fails a phase 3 trial in non-small cell lung cancer (NSCLC)
PharmaTimes
DECEMBER 21, 2023
The condition affects around 270,935 people in England and 16,090 people in Wales - News - PharmaTimes
pharmaphorum
DECEMBER 21, 2023
NICE backs NHS use of digital COPD rehab programmes, myCOPD and SPACE for COPD, as an alternative to face-to-face consultations
PharmaTimes
DECEMBER 21, 2023
Bowel cancer is currently the third most common type of cancer in England - News - PharmaTimes
pharmaphorum
DECEMBER 21, 2023
Lilly partners with Fauna Bio in $494m deal to see if a hibernating squirrel's genomics could unlock new obesity drug targets.
PharmaTimes
DECEMBER 21, 2023
The National Institute for Health and Care Excellence (NICE) has published final guidance announcing a five-year roll-out of a wearable technology for patients living with type 1 diabetes. The new hybrid closed loop systems have proven to be more effective in maintaining healthy blood glucose levels than standard care. The new guidance followed a review of a clinical trial and real-world evidence by the University of Warwick and Warwick Medical School, funded by the National Institute for Health
pharmaphorum
DECEMBER 21, 2023
Indivior has secured a $111 million BARDA supply contract in the US for its Opvee intranasal therapy for treating opioid overdose
PharmaTimes
DECEMBER 21, 2023
The NHS has announced the expansion of its home-testing kits for bowel cancer in an effort to detect signs of the disease and diagnose it earlier. The expansion of the NHS Bowel Cancer Screening Programme aligns with the health service’s aim of detecting cancers at an earlier stage when they are easier to treat. Currently the third most common type of cancer in England and responsible for almost 43,000 new cases in the UK every year, bowel cancer starts in the large bowel (colon) and the back pa
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
pharmaphorum
DECEMBER 21, 2023
FDA issues a second complete response letter to MSD's gefapixant for chronic cough, giving GSK a chance to catch up with camlipixant
PharmaTech
DECEMBER 21, 2023
The final guidance document provides recommendations for designing a new registry or using an existing registry to support decisions regarding safety and effectiveness of a drug.
pharmaphorum
DECEMBER 21, 2023
Servier has been found guilty of fraud and deception over weight loss therapy Mediator by French appeals court, and is fined €431 million
Rep-Lite
DECEMBER 21, 2023
If you’re in charge of hiring medical staff, you know how complex and challenging it can be to find the right candidates. Whether you’re trying to fill a small clinic or a large hospital, medical staff recruitment requires a comprehensive strategy addressing many factors. In this guide, we’ll explore the ins and outs of medical staff recruitment, from identifying your needs to sourcing candidates and making successful hires.
Pharmacy Times
DECEMBER 21, 2023
Pharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.
Pharmaceutical Technology
DECEMBER 21, 2023
Discover a groundbreaking method to treat cancer using a combination of mitochondrial and Bcl-2 inhibitors. Learn more about this patent's innovative approach.
PharmaVoice
DECEMBER 21, 2023
Closer scrutiny of pharma deals has made the M&A landscape trickier as a new approach seeks to expand the competitive arena.
Pharmacy Times
DECEMBER 21, 2023
Overtime, children can outgrow food allergies, like milk and eggs—however, children with private insurance are more likely to outgrow allergies than those with public insurance.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
266 
Let's personalize your content